Stock Information
Sarepta Therapeutics Inc (SRPT)
Ticker Symbol: SRPT
Exchange: NASDAQ
Sector: Biotechnology
Market Cap: $1,841.25 mil
Piotroski score: 6
PE Ratio: N/A
EPS (TTM): -1.82
Revenue (TTM): $18.73 M
Dividend Yield: N/A
ROE: -9.96%
Latest News
-
What Is The Case For Waiting On Moderna Stock?
Fri, Oct 16, 2026 2:44 PM
-
Sarepta Therapeutics Presents New Preclinical Data Demonstrating Robust Knockdown of Pathogenic DMPK RNA in the Nucleus with SRP-1003 in DM1 at 2026 Oligonucleotide Therapeutics Society Annual Meeting
Wed, Oct 14, 2026 12:30 PM
-
Where Could Moderna's Next Growth Come From?
Mon, Oct 12, 2026 9:01 PM
-
Global Capsid Tropism Screening Platforms Market Report 2026 | Capitalize on 14.4% CAGR to $1.45B by 2030 as Sarepta, Voyager, REGENXBIO and Dyno Scale AI and NGS Screening
Mon, Oct 12, 2026 1:59 PM
Key Financials
Financial data not available
